企業プロフィール
Rezolute 株価・ニュース・カタリスト
- ティッカー:
- RZLT
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
5.01 USD (-1.57%)
終値
最終更新: 2026年8月24日
385M USD
時価総額
株価変動の要因
As of Aug 24, 2026, RZLT closed down 1.57% at $5.01. No new same-company headline was identified in the current news window.
企業概要
事業概要
Rezolute is a rare-disease and endocrine company focused on hypoglycemia and metabolic disorders. Its programs target difficult hormonal diseases with few effective therapies.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Rezolute sits in specialty biotechnology.
ビジネスモデルの特徴
The business depends on clinical data, dose strategy, and the chance to build value in rare endocrine disease.
バイオ業界での位置付け
Rezolute is a small-cap rare-disease catalyst name whose valuation depends on proof-of-concept and execution.
今後のカタリスト
- Rezolute’s catalyst is ersodetug in hyperinsulinism, where each clinical and regulatory step can materially change the valuation. The market will care about whether the program keeps moving toward a real rare-disease opportunity.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。